Literature DB >> 20382508

Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.

E Paul O'Donnell, Kimberly K Scarsi, Marc H Scheetz, Michael J Postelnick, Joanne Cullina, Manu Jain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382508     DOI: 10.1016/j.ijantimicag.2010.02.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

1.  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.

Authors:  Todd MacKenzie; Alex H Gifford; Kathryn A Sabadosa; Hebe B Quinton; Emily A Knapp; Christopher H Goss; Bruce C Marshall
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

2.  d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.

Authors:  Daniel J Fox; Morris D Cooper; Cristian A Speil; Melissa H Roberts; Susan C Yanik; Robert P Meech; Tim L Hargrove; Steven J Verhulst; Leonard P Rybak; Kathleen C M Campbell
Journal:  J Cyst Fibros       Date:  2015-07-10       Impact factor: 5.482

Review 3.  Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

4.  Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis.

Authors:  Min Dong; Anna V Rodriguez; Chelsea A Blankenship; Gary McPhail; Alexander A Vinks; Lisa L Hunter
Journal:  J Antimicrob Chemother       Date:  2021-10-11       Impact factor: 5.790

5.  Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study.

Authors:  Julia C Espel; Hannah L Palac; Joanne F Cullina; Alexandria P Clarke; Susanna A McColley; Michelle H Prickett; Manu Jain
Journal:  BMC Pulm Med       Date:  2017-11-29       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.